New hope for stopping the most dangerous seizures?
NCT ID NCT05684978
Summary
This study aimed to see if the drug perampanel could safely and effectively stop a dangerous condition called refractory status epilepticus, where seizures are continuous and don't respond to standard emergency medications. It planned to enroll 25 adult patients whose seizures required strong anesthetic drugs in the ICU. The main goal was to see if perampanel could help doctors safely stop the anesthetic infusions without the seizures returning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY STATUS EPILEPTICUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wayne State University
Detroit, Michigan, 48201, United States
Conditions
Explore the condition pages connected to this study.